Table 3

Dynamic pulmonary function in PLWHIV and uninfected controls stratified by smoking status

PLWHIV (n=1083)Controls (n=12 074)P value*Never smoking PLWHIV (n=360)Never smoking controls (n=5717)P value†
FEV1/FVC<LLN, n (%)114 (10.6)1278 (10.6)1.015 (4.2)378 (6.6)0.09
 FEV1≥80% predicted29 (25.4)747 (58.5)6 (40.0)246 (65.1)
 FEV150%–79% predicted69 (60.5)463 (36.2)8 (53.3)128 (33.9)
 FEV130%–49% predicted13 (11.4)63 (4.9)1 (6.7)3 (0.8)
 FEV1<30% predicted3 (2.6)5 (0.4)0 (0.0)1 (0.3)
FEV1/FVC<0.7 and FEV1predicted <80%108 (10.0)696 (5.8)<0.00114 (3.9)177 (3.1)0.50
 FEV150%–79% predicted92 (85.1)625 (89.8)13 (92.9)172 (97.2)
 FEV130%–49% predicted13 (12.0)66 (9.5)1 (7.1)4 (2.2)
 FEV1<30% predicted3 (2.8)5 (0.7)0 (0.0)1 (0.6)
  • *Comparing PLWHIV with controls.

  • †Comparing never smoking PLWHIV with never smoking controls.

  • LLN, lower limit of normal; PLWHIV, people living with HIV.